Overexpressed ATP7B protects mesenchymal stem cells from toxic copper.
Sauer V, Siaj R, Todorov T, Zibert A, Schmidt HH
Research article (journal)Abstract
Wilson's disease (WD) is characterized by accumulation of high levels of copper in liver due to malfunction of copper transporter ATP7B which is central for copper homeostasis. Here we report for the first time that mesenchymal stem cells (MSC) derived from bone marrow express detectable levels of ATP7B. The role of ATP7B overexpression for MSC survival and selection in high copper was investigated. Hepatoma cell line HepG2 that has a high intrinsic expression of ATP7B served as a control. Using retroviral vector a significant higher expression level of ATP7B could be achieved in MSCs. Whereas copper treatment resulted in cell death in untransduced MSCs, viability assays demonstrated a unique copper resistance of ATP7B overexpressing MSCs that outcompeted HepG2. In long-term cell culture stable transgene expression for up to 9weeks was shown for ATP7B overexpressing MSCs which rapidly overgrew untransduced cells. Our findings suggest that ATP7B overexpression provides an important selection advantage to MSCs in high copper microenvironments, and may represent novel cell transplants for therapy of WD.
Details about the publication
Authors from the University of Münster
| Sauer, Vanessa Daniela | Clinic for Transplant Medicine |
| Schmidt, Hartmut | Clinic for Transplant Medicine |
| Siaj, Ramsi | Clinic for Transplant Medicine |
| Zibert, Andree | Clinic for Transplant Medicine |